Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024
Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24 Percentage weight loss is in line with pivotal trial results using standard obesity thresholds May 31, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines News and commentary from the endocrinology world May 14, 2024
Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill News and commentary from the endocrinology world May 07, 2024
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation News and commentary from the endocrinology world Apr 30, 2024
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On News and commentary from the endocrinology world Apr 23, 2024
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs? News and commentary from the endocrinology world Apr 16, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Wegovy Approved for Major Heart Disease Prevention New indication for patients with obesity or overweight and a history of cardiovascular disease Mar 08, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Subclasses of Steatotic Liver Disease Can Help Determine Prognosis Risk of liver decompensation increased progressively when alcohol intake came into play Jan 18, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves News and commentary from the endocrinology world Dec 12, 2023
USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
